Vascular Closure System for Large Bore Venous Access

The Venock vascular closure device will address a tremendously growing medical need and will have a significant positive impact on the clinical practice of interventional cardiologists.

LEARN MORE

Venock Inc / Venock Medical GmbH

Medical Need

THERAPEUTIC PROCEDURES THAT REQUIRE
LARGE BORE VENOUS ACCESS CLOSURE

Current Trans-Venous Procedures

Current therapies that require large bore venous vascular access:

 

  • ASD Closure
  • Left Arterial Appendix Occluder
  • Mitral Valve Repair (currently only one technology available)
  • Vena Cava Filter
  • Atrial Ablation
  • Pulmonary Embolectomy
  • Venous Thrombectomy
     

These trans-venous therapies add up to approximately 5 million procedures per year in USA and Europe.

Upcoming Trans-Venous Procedures

A dramatic increase in interventional procedures that require large bore venous vascular access site is expected once novel technologies under development for structural heart treatment in development will mature.

  • Transcatheter Mitral Valve Repair
  • Transcatheter Mital Valve Prosthesis Implantation
  • Transcatheter Tricuspid Valve Repair
  • Transcatheter Tricuspid Valve Prosthesis Implantation
  • Intra-Atrial Shunt Therapy
  • Left Ventricle Restoration
  • Left Ventricle Volume Reduction
  • Right Ventricle Assist Devices

As soon as these procedures are fully developed and utilized, the market for large bore venous access closure is expected to grow to 30 million procedures per year in the USA and Europe.

As of today there exists no effective vascular closure device for large bore punctures of venous vessels in the clinical practice.

Solution

The Venock System

The Venock vascular closure device is a percutaneous hand held device for automated closure of a large bore puncture in the femoral vein following an interventional procedure. The device is inserted over the already positioned guidewire in the vein and the perforation is tightly sealed within 1-2 minutes procedure time.

Advantages of Venock Vascular Closure Device

Closure within 1-2 minutes

The current practice is to stop venous bleeding with half an hour manual pressure, followed by compression bandage and 6 hours immobilization.

Quick sealing of the vein puncture will allows for earlier patient mobilization.

Earlier discharge

The current practice is to keep patients overnight in the hospital, being immobilized and bedridden with a compression bandage and sand sack.

Quick sealing of the vein puncture will allow for earlier patient discharge.

Less complications

Sealing of the vein puncture by compression results in hematoma, pain and swelling. Patient immobilization increases the risk for vein thrombosis.

Reliable and quick sealing of vein puncture will reduce serious complications.

Cost savings

Quick sealing of the vein puncture will free up resources and more interventional procedures can be converted from inpatient to outpatient settings.

Consequently, the utilization of Venock Closure device is cost effective.

WOULD YOU LIKE TO LEARN MORE?

Our Management Team

Powered by People

Terry Barnes

CHIEF EXECUTIVE OFFICER

Learn more

Dipl.-Kfm. Marcus Irsfeld

CHIEF FINANCIAL OFFICER

Learn more

Dr. Wolfgang Goetz

FOUNDER & CHAIRMAN OF THE BOARD

Learn more

Our Achievements

News

First closing of Seed Investment Round

2019-03-01: Newly founded and privately held U.S. medical technology company Venock, Inc. announces first closing of seed financing.

Read more …

Contact

Get in Touch

HEAD QUARTER USA

VENOCK INC.

521 Fifth Avenue, Floor 17 | New York, NY 10175 | USA

OPERATIONS GERMANY

VENOCK MEDICAL GMBH

c/o WeWork | Neuturmstrasse 5 | 80331 München | Germany

MEETING US AT EVENTS

We plan to attend the following events and are looking forward to arranging a meeting with you.

 

Tuesday, 09.04.19

MedTech Strategist Dublin 2019

The annual Innovation Summit Dublin, located in the heart of Ireland's technology sector, is recognized as the leading medical technology investment forum in Europe and brings together more than 450 leading experts, innovators, and key decision-makers to discuss the critical challenges facing the ever-evolving global medtech community.

Wednesday, 08.05.19

Southeast MedTech Forum 2019

The inaugural Southeast MedTech Forum 2019 was created to alleviate that challenge and provide medtech founders, CEOs, and investors with an intimate forum, and an agenda custom designed to provide attendees with valuable and actionable insights into the evolving medical device industry.

Tuesday, 21.05.19

euroPCR

The official annual meeting of the European Association of Percutaneous Cardiovascular Interventions.

Are you interested in an investment or in a joint development?
Please contact us.

WIPANO Patentförderung

Förderprogramm WIPANO des Bundesministeriums für Wirtschaft und Energie

External link: http://www.wipano.de